ClinicalTrials.Veeva

Menu

Expanding Access to Comprehensive Geriatrics Care Via Telehealth (TeleGRACE)

VA Office of Research and Development logo

VA Office of Research and Development

Status

Terminated

Conditions

Geriatric Syndrome

Treatments

Other: TeleGRACE

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT05166603
QUE HX0003205-01 (Other Grant/Funding Number)
QUX 21-007

Details and patient eligibility

About

The overall objective of the TeleGRACE project is to improve the care and outcomes of older Veterans with a recent inpatient stay by expanding access to the evidence-based GRACE program, by evaluating a telehealth implementation.

Full description

The TeleGRACE evaluation will focus on three primary aims and a secondary aim:

Primary Aim 1: To examine the effectiveness of the TeleGRACE program, the investigators designed a randomized controlled implementation trial (RCT) powered for the primary outcome of 90-day all-cause mortality. The investigators will also examine its effectiveness for the secondary outcomes including 90-day readmissions, 1-year ED utilization (VA and non-VA), 1-year all-cause readmissions, 1-year mortality, as well as patient, caregiver, and staff satisfaction. The investigators hypothesize that patients who receive TeleGRACE will have lower 90-day mortality than patients in usual care.

Primary Aim 2: to examine the implementation of the TeleGRACE program. The implementation strategy is reflecting & evaluating. Implementation outcomes are based on the REAIM framework and include reach, efficacy (Aim 1), and implementation (total number of Veterans served, fidelity).

Primary Aim 3: to conduct a business-case analysis (BCA). The business case analysis will calculate the net financial savings or loss for TeleGRACE as the difference in the overall intervention costs and savings due to downstream benefits for patients receiving TeleGRACE versus usual care controls.

Enrollment

111 patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Veterans discharged from the Indianapolis VA medical center (VAMC) for an medical/surgical diagnosis (excludes substance use disorder-related admissions; excludes planned admissions) within the prior week
  • Age 70 years
  • Not enrolled in home-based primary care (HBPC)
  • Not enrolled in hospice
  • Not in dialysis
  • Primary care visit within VA in the prior 2 years
  • Not residing in nursing home, skilled nursing facility, or CLC.
  • Living >20 miles but <60 miles from the Indianapolis VAMC facility
  • CAN score 95th percentile for mortality or missing CAN score
  • Discharged from the hospital alive

Exclusion criteria

  • Patients who have been randomized to the control arm after their index hospitalization who become readmitted to the hospital may not be re-randomized.
  • By definition, GRACE patients are not eligible for TeleGRACE due to the drive distance >20 miles from the Indianapolis VAMC
  • Enrolled in home-based primary care (HBPC)
  • Enrolled in hospice
  • Dialysis (hemodialysis or peritoneal dialysis)
  • Residing in nursing home, skilled nursing facility, or CLC.
  • Living <20 miles or 60 miles from the Indianapolis VAMC facility

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

111 participants in 2 patient groups

TeleGRACE
Experimental group
Description:
Patients receive a virtual home visit and care from the GRACE team
Treatment:
Other: TeleGRACE
Usual Care
No Intervention group
Description:
Patients receive usual care

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems